data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Vir Biotechnology
(NASDAQ:VIR)
$25.74
-0.27[-1.04%]
Last update: 1:24PM
15 minutes delayed
Day High/Low25.14 - 26.14
52 Week High/Low18.21 - 58
Open / Close25.76 / -
Float / Outstanding82.4M / 132.4M
Vol / Avg.259.5K / 1.6M
Mkt Cap3.4B
P/E2.85
50d Avg. Price23.36
Div / Yield-
Payout Ratio-
EPS3.93
Total Float82.4M

Vir Biotechnology (NASDAQ:VIR), Quotes and News Summary

Vir Biotechnology (NASDAQ: VIR)

Day High/Low25.14 - 26.14
52 Week High/Low18.21 - 58
Open / Close25.76 / -
Float / Outstanding82.4M / 132.4M
Vol / Avg.259.5K / 1.6M
Mkt Cap3.4B
P/E2.85
50d Avg. Price23.36
Div / Yield-
Payout Ratio-
EPS3.93
Total Float82.4M
Benzinga - Sponsored
Benzinga - 3 days ago
Benzinga - May 20, 2022, 4:29PM
Benzinga - May 12, 2022, 3:00PM
Benzinga - May 12, 2022, 6:18AM
Benzinga - May 6, 2022, 6:47AM
Benzinga - May 5, 2022, 5:26PM
Benzinga - May 2, 2022, 1:26PM
Benzinga - Apr 27, 2022, 8:41AM
Benzinga - Apr 6, 2022, 2:20PM
Benzinga - Mar 30, 2022, 11:08AM
Benzinga - Mar 30, 2022, 6:24AM
Benzinga - Mar 29, 2022, 5:19PM
Benzinga - Mar 28, 2022, 7:05AM
Benzinga - Mar 28, 2022, 6:38AM
Benzinga - Mar 11, 2022, 10:51AM
load more
Sector: Health Care.Industry: Biotechnology
Vir Biotechnology Inc is a commercial-stage immunology company focused on treating and preventing infectious diseases. It has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA, through internal development, collaborations, and acquisitions. The company's pipeline consists of product candidates targeting hepatitis B virus, or HBV, influenza A, human immunodeficiency virus, or HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue and license revenue.
Read More

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-04
REV
Q1 2022Est.ActualSurprise
EPS3.7803.850 0.0700
REV836.970M1.232B395.030M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Vir Biotechnology Questions & Answers

Q
How do I buy Vir Biotechnology (VIR) stock?
A

You can purchase shares of Vir Biotechnology (NASDAQ: VIR) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Vir Biotechnology's (VIR) competitors?
Q
What is the target price for Vir Biotechnology (VIR) stock?
A

The latest price target for Vir Biotechnology (NASDAQ: VIR) was reported by HC Wainwright & Co. on Thursday, May 12, 2022. The analyst firm set a price target for 125.00 expecting VIR to rise to within 12 months (a possible 385.63% upside). 11 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Vir Biotechnology (VIR)?
A

The stock price for Vir Biotechnology (NASDAQ: VIR) is $25.74 last updated Today at June 30, 2022, 5:24 PM UTC.

Q
Does Vir Biotechnology (VIR) pay a dividend?
A

There are no upcoming dividends for Vir Biotechnology.

Q
When is Vir Biotechnology (NASDAQ:VIR) reporting earnings?
A

Vir Biotechnology’s Q2 earnings are confirmed for Thursday, August 4, 2022.

Q
Is Vir Biotechnology (VIR) going to split?
A

There is no upcoming split for Vir Biotechnology.

Q
What sector and industry does Vir Biotechnology (VIR) operate in?
A

Vir Biotechnology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.